Dover, MA, United States of America

David S Garvey

USPTO Granted Patents = 101 

 

 

Average Co-Inventor Count = 3.0

ph-index = 21

Forward Citations = 1,310(Granted Patents)

Forward Citations (Not Self Cited) = 1,066(Oct 12, 2025)


Inventors with similar research interests:


Location History:

  • Lake Forest, IL (US) (1993 - 1995)
  • Lansdale, PA (US) (1996)
  • Waltham, MA (US) (1997 - 2007)
  • Dover, MA (US) (1998 - 2018)

Company Filing History:


Years Active: 1993-2018

Loading Chart...
Loading Chart...
Loading Chart...
101 patents (USPTO):

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, assignees, and patents, I will provide you with an article about inventor David S Garvey based on the given data.

Title: Spotlight on David S Garvey - Pioneering Innovations in Ophthalmic Treatments

Introduction:

David S Garvey, a prolific inventor based in Dover, MA (US), has made significant contributions to the field of ophthalmic treatments, holding an impressive total of 101 patents. His groundbreaking work focuses on developing compounds and compositions to address various ophthalmic conditions, particularly those related to toxic visual cycle products and opsin proteins.

Latest Patents:

Garvey's recent patents include Opsin-binding ligands, compositions, and methods of use. These patents unveil compounds and compositions tailored to treat ophthalmic conditions stemming from the accumulation of toxic visual cycle products in the eye, such as dry adult macular degeneration. The inventions also target conditions linked to the misfolding and mis-localization of mutant opsin proteins. Additionally, the patents outline therapeutic methods and synthesis techniques for these innovative agents.

Career Highlights:

Throughout his career, Garvey has showcased his expertise by working with renowned companies such as Nitromed, Inc. and Nicox S.A. His collaborations with these industry leaders have further validated his pioneering research in the field of ophthalmology and pharmaceuticals.

Collaborations:

Notable collaborators of David S Garvey include L Gordon Letts and Inigo Saenz de Tejada, who have played integral roles in advancing the development and implementation of his innovative solutions for ophthalmic disorders.

Conclusion:

In conclusion, David S Garvey's dedication to pushing the boundaries of ophthalmic treatments through his inventive compounds and therapeutic methods is truly commendable. His impressive patent portfolio stands as a testament to his commitment to improving eye care and addressing critical medical needs. Garvey's contributions continue to inspire advancements in the field, paving the way for enhanced treatments and better outcomes for patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…